We always have a big presence at the ARVO annual meeting, and this year is no exception, with over fifty of our researchers presenting their groundbreaking work.
ARVO is the largest and most respected eye and vision research organization in the world, presenting research projects at their annual meeting is highly competitive and to have this many projects presented is a real achievement.
This really is a huge credit to us, showcasing the extensive and pioneering research taking place in partnership between UCL & Moorfields.
If you will be attending ARVO and would like to find out more about the work we're doing; Anthony Khawaja has compiled the 2017 definitive guide to UCL Institute of Ophthalmology and Moorfields Eye Hospital presentations at ARVO to help you know where to find us.
May 6th
| Start Time | End Time | Speakers | Title | Presentation | Location |
| 11:05 | 11:25 | Adnan Tufail | Big Data: Current status and future directions | Applications of Machine Learning and Deep Learning | Room 307 |
| 14:00 | 14:30 | Ana Quartilho | Demystifying statistics and research for ophthalmic investigators | Fuss about p-value: How do I compare two treatments? Why is the p-value never enough? | Room 309 |
| 15:15 | 15:45 | Ana Quartilho | Demystifying statistics and research for ophthalmic investigators | Missing data: Why does it matter? How to approach the challenges it presents? | Room 309 |
May 7th
| Start Time | End Time | Speakers | Title | Presentation | Location |
| 08:30 | 10:15 | Maria Gemenetzi | AMD Imaging 1 | A0034: Optical coherence tomography angiography in treated neovascular age related macular degeneration | Exhibit/ Poster Hall |
| 13:30 | 15:15 | Karen Eastlake | Determinants of PR development and repair | A0207: Comparison of zebrafish retinal proteins during experimental degeneration and regeneration using quantitative proteomics | Exhibit/ Poster Hall |
| 13:30 | 15:15 | Bish Pal | AMD Imaging 2 | A0250: Quantitative Assessment and Comparison Of Choroidal Neovascular Membranes Of Different Etiologies Using Two Different Optical Coherence Tomography Angiography Devices | Exhibit/ Poster Hall |
| 13:30 | 15:15 | Vijay Tailor | Structural/functional genomics and gene variants | B0147: The Oculome: a genetic test to diagnose a diverse range of ocular birth anomalies | Exhibit/ Poster Hall |
| 13:30 | 15:15 | Tobias Weinrich Weinrich | Biochemistry and molecular biology of the retina | B0177: Does S cone vulnerability reside in their mitochondria? | Exhibit/ Poster Hall |
| 13:30 | 15:15 | Zaid Shalchi | Cataract Surgery Outcomes and Epidemiology | B0629: Characterizing posterior capsule rupture during cataract surgery in eyes with prior intravitreal injection | Exhibit/ Poster Hall |
| 13:48 | 13:53 | Peng Khaw | Addressing global blindness and eye diseases through research | Global Experimental Medicine - the UNITE Consortium | Room 310 |
| 13:53 | 13:58:0 | Richard Lee | Addressing global blindness and eye diseases through research | Global Experimental Medicine - the UNITE Consortium | Room 310 |
| 15:15 | 17:00 | Maria Eleftheriadou | AMD and anti-VEGF therapy 2 | A0053: Three-Year Real World Outcomes of Aflibercept Treatment of Treatment-naïve Patients with Neovascular Age-related Macular Degeneration | Exhibit/ Poster Hall |
| 15:15 | 17:00 | Valerie Saw | Cataract Surgery - IOLs | B0642: Outcomes of the Haigis-L formula for calculating intraocular lens power after myopic and hyperopic laser refractive surgery in a tertiary teaching hospital | Exhibit/ Poster Hall |
May 8th
| Start Time | End Time | Speakers | Title | Presentation | Location |
| 08:30 | 10:15 | Tjebo Heeren | OCT applications | A0024: Progression of Ellipsoid Zone Loss correlates with Change of Scotoma Size in Macular Telangiectasia Type 2. | Exhibit/ Poster Hall |
| 08:30 | 10:15 | Daren Hanumunthadu | OCT applications | A0036: Comparison of spectral-domain and swept-source optical coherence tomography in the detection of neovascular age related macular degeneration disease activity | Exhibit/ Poster Hall |
| 08:30 | 10:15 | Anastasia Tasiopoulou | OCT applications | A0053: Characteristic optical coherence tomography findings in a case series of patients with primary vitreoretinal lymphoma: A novel aid to early diagnosis. | Exhibit/ Poster Hall |
| 08:30 | 10:15 | Tunde Peto | Retinal Diseases | B0174: Retinal vascular calibres in older HIV-positive men compared to HIV-negative and younger HIV+ controls | Exhibit/ Poster Hall |
| 08:30 | 10:15 | Eleni Vrizidou | Retinal vascular diseases I (excluding diabetes) | B0386: 1 year-Real world clinical audit of aflibercept use in the management of macular edema secondary to central retinal vein occlusion at Moorfields Eye Hospital | Exhibit/ Poster Hall |
| 10:00 | 10:15 | Alessia Fiorentino | Genotype-phenotype correlations, prevalence studies and novel gene defects | Mutations in the X-linked gene PRPS1 cause retinal degeneration in females | Room 314 |
| 11:00 | 12:45 | J Emanuel Carvalho | Clinical applications of OCT angiography | A0117: Assessment Of Subclinical Microvascular Flow Characteristics In Aneurysmal Retinal Vasculitis Using Optical Coherence Tomography Angiography | Exhibit/ Poster Hall |
| 14:05 | 14:25 | Gary Rubin | LV: Reading with low vision: What we know and need to know | Future directions for low vision reading research: Building the evidence base - Presented by the 2017 Recipient of the Oberdorfer Award in Low Vision Research | Room 308 |
| 14:05 | 14:10 | Karen Bonstein | Novel models and trends for accelerating applied ophthalmic product discovery and development | How patient and public involvement is influencing the relevancy of modern healthcare | Room 310 |
| 14:10 | 14:15 | Andrew Skilton | Novel models and trends for accelerating applied ophthalmic product discovery and development | How patient and public involvement is influencing the relevancy of modern healthcare | Room 310 |
| 15:45 | 17:30 | Jonathan Clarke | Clinical Trials and Drug Studies I | A0163: Efficacy and safety of a new preservative-free fixed combination latanoprost-timolol (T2347) for open-angle glaucoma or ocular hypertension | Exhibit/ Poster Hall |
| 15:45 | 17:30 | Cynthia Yu-Wai-Man | Genetics of glaucoma | A0246: Genome-wide RNA-Sequencing analysis reveals a distinct fibrosis gene signature in the conjunctiva after glaucoma surgery | Exhibit/ Poster Hall |
| 15:45 | 17:30 | Sophia Zagora | Uveitis: Diagnosis, Epidemiology, Quality of Life | A0253: Assessment of structure function correlation and response to treatment in uveitic cystoid macula edema using non-invasive Optical Coherence Tomography Angiography | Exhibit/ Poster Hall |
| 15:45 | 17:30 | Chrysoula Koutsiouki | Uveitis: Diagnosis, Epidemiology, Quality of Life | A0267: Retinal Microvasculature changes in Birdshot Retinochoroiditis (BRC) detected by Optical Coherence Tomography Angiography | Exhibit/ Poster Hall |
| 15:45 | 17:30 | Matthew Pilgrim | Bruch's membrane and choroid in macular disease | B0220: A mineralomic study of the retinal pigment epithelium-Bruch’s membrane complex in human eyes with age-related macular degeneration | Exhibit/ Poster Hall |
| 16:30 | 16:45 | Rupert Strauss | Inherited retinal diseases and mactel | Progression of Atrophic Lesions Determined by Fundus Autofluorescence: The Natural History of the Progression of Atrophy secondary to Stargardt Disease (ProgStar) Study | Ballroom 3 |
May 9th
| Start Time | End Time | Speakers | Title | Presentation | Location |
| 08:30 | 10:15 | Mahmood El-Gasim | Diabetic Eye Disease | B0543: Changes in glycated hemoglobin levels following consultation with diabetes specialist nurse in retinal clinics | Exhibit/ Poster Hall |
| 09:45 | 10:00 | Panayiota Founti | Clinical Trials and Drug Studies II | Risk factors for glaucoma progression in the United Kingdom Glaucoma Treatment Study (UKGTS) | Ballroom 4 |
| 11:00 | 12:45 | Adam Dubis | Blood flow | A0028: Retinal morphology and vessel oxygen saturation in normal and diabetic patients | Exhibit/ Poster Hall |
| 11:00 | 12:45 | Sobha Sivaprasad | AMD Clinical Research 2 | B0347: Content validity of the NEI VFQ-25 in patients with geographic atrophy | Exhibit/ Poster Hall |
| 11:00 | 12:45 | James Tee | Retinitis pigmentosa (clinical) | B0370: Assessment of Interocular Disease Progression in Retinitis Pigmentosa GTPase Regulator (RPGR)-associated Retinopathy with Quantitative Fundus Autofluorescence (FAF) Image Analysis | Exhibit/ Poster Hall |
| 11:00 | 12:45 | Rola Ba-Abbad | Retinitis pigmentosa (clinical) | B0357: Dysplasia and degeneration in NR2E3 retinopathy: an imaging study | Exhibit/ Poster Hall |
| 11:00 | 12:45 | Annegret Dahlmann-Noor | Papilledema, IIH and Optic Nerve | B0580: Ultrasonography, OCT and OCT-angiography in the diagnostic workup of children with suspected papilledema | Exhibit/ Poster Hall |
| 13:40 | 14:00 | Tessa Dekker | VSS at ARVO - Functional Brain Imaging in Development and Disorder | Development of retinotopic representations in visual cortex during childhood | Room 309 |
| 15:45 | 17:30 | Moritz Daniel | Trabecular Meshwork and Ciliary Body | A0089: Dynamic changes of iridocorneal angle morphology during accommodation in healthy children | Exhibit/ Poster Hall |
| 15:45 | 17:30 | Almudena Sacristan Reviriego | Cellular mechanisms of retinal diseases and ocular therapeutics | B0156: Functional assessment of AIPL1 variations identified in Leber Congenital Amaurosis patients | Exhibit/ Poster Hall |
| 15:45 | 17:30 | Ferenc Sallo | Macular diseases (non-inherited) | B0312: Distribution and progression patterns of retinal low-reflective intraretinal spaces in Type 2 Idiopathic Macular Telangiectasia. | Exhibit/ Poster Hall |
| 15:45 | 17:30 | Laure Van Bol | Macular diseases (non-inherited) | B0315: Characterisation of phenotypes of poppers maculopathy and their link with the visual prognosis and the resolution of OCT changes | Exhibit/ Poster Hall |
| 15:45 | 17:30 | Anthony Khawaja | Glaucoma | B0490: A protective association of selective serotonin reuptake inhibitors and a harmful association of calcium channel blockers for primary open-angle glaucoma identified in a healthcare database analysis | Exhibit/ Poster Hall |
May 10th
| Start Time | End Time | Speakers | Title | Presentation | Location |
| 08:30 | 10:15 | Izabela Klaska | Angiogenesis: Basic Mechanisms | B0036: Human opticin reduces pathological preretinal neovascularization in the mouse model of oxygen-induced retinopathy. | Exhibit/ Poster Hall |
| 11:00 | 12:45 | Sahar Awwad | Drug delivery I | B0065: In vitro in vivo correlation of dexamethasone TIPS particles | Exhibit/ Poster Hall |
| 11:00 | 12:45 | Panagiotis Vasilopoulos | Macular diseases (inherited) | B0512: Clinical, optical coherence tomography and fundus autofluorescence findings in atrophic maculopathy associated with pseudoxanthoma elasticum | Exhibit/ Poster Hall |
| 11:00 | 12:45 | Simona Degli Esposti | Vision in aging and disease | B0648: Exploration of the phenomenon of regression to the mean in visual acuity measurements in patients with age-related macular degeneration | Exhibit/ Poster Hall |
| 11:00 | 11:15 | Neruban Kumaran | Color vision, low vision | Severe Loss of Tritan Colour Discrimination in RPE65 Associated Leber Congenital Amaurosis | Room 316 |
| 13:21 | 13:37 | David Garway-Heath | MOI: Advanced interpretation of structural retinal optical coherence tomography | Understanding Visual Function Through Imaging | Ballroom 2 |
| 15:45 | 17:30 | Roy Schwartz | Imaging technology and applications | A0340: The distribution of macular pigment in different macular diseases | Exhibit/ Poster Hall |
| 15:45 | 17:30 | Mali Okada | Clinical electrophysiology | B0275: Electrophysiological Characterization of Macular Telangiectasia Type 2 (MacTel) | Exhibit/ Poster Hall |
| 15:45 | 17:30 | Corrado Gizzi | Surgery and Wound Healing | B0362: Is bleb needling after failed trabeculectomy a procedure worth considering? 5 year outcome with a standardized technique. | Exhibit/ Poster Hall |
| 16:50 | 17:10 | Peter Coffey | The bench and the bedside: Who is the instructor? - Minisymposium | Human Embryonic Stem Cell derived Retinal Pigment Epithelium transplantation in severe exudative Age-Related Macular Degeneration: so far so visual. | Room 310 |
| 17:00 | 17:15 | Gary Rubin | Low Vision Devices and Rehabilitation | First results from the EFFECT Trial, an RCT of eccentric viewing training for patients with AMD | Room 308 |
May 11th
| Start Time | End Time | Speakers | Title | Presentation | Location |
| 08:30 | 10:15 | Sarah Houston | Neurodegenerative Diseases and Brain Trauma | B0005: Microvascular Abnormalities and Inner Retinal Thickness in Multiple Sclerosis | Exhibit/ Poster Hall |
| 08:30 | 10:15 | Weixin Wang | Non-neural cells of the retina: Glia and Microglia | B0545: Comparative effects of Transforming growth factor-β1 and Heparin-binding epidermal growth factor on the production of anti-oxidants by human Müller glial cells | Exhibit/ Poster Hall |
| 08:30 | 10:15 | Reena Chopra | Advancements in OCT | B0597: Human Factor and Usability Testing of a Binocular OCT System - EASE Study | Exhibit/ Poster Hall |
| 11:45 | 12:00 | Gus Gazzard | Surgery, Laser Therapy, Wound Healing | 5574: LiGHT: Laser in Glaucoma and Ocular Hypertension Trial – Methodology and Baseline characteristics of a multicentre randomised controlled trial | Ballroom 3 |
Close
